Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Addictions Therapeutics Market from 2024 to 2025?

In the past few years, there has been a significant growth in the market size of addiction therapeutics. The market that stood at $7.05 billion in 2024 is anticipated to reach $7.48 billion in 2025, projecting a compound annual growth rate (CAGR) of 6.1%. The growth during this historical period can be linked to several factors, which include escalating use of addictive substances like alcohol, tobacco, and drugs, increased public awareness along with a rising prevalence of substance abuse disorders. Also, the legalization of marijuana in different states and the increased funds and support for initiatives related to addiction treatment contribute to the growth.

What Is the Projected Market Size of the Addictions Therapeutics Market?

In the years to come, the market for addiction therapeutics is set to experience significant growth, growing to $9.62 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. The projected growth during this period is largely due to increasing awareness campaigns around drug use, the emergence of synthetic drugs and novel psychoactive substances, lifestyle changes and stress-related factors, growth in rehabilitation facilities, and the inclusion of telehealth services in addiction treatment. Key trends forecasted for this period encompass advancements in diagnostic technology, developments in neuroscience, alliances and collaborations amongst pharmaceutical firms and other stakeholders to tackle addiction issues, and the launch of innovative drugs for addiction therapeutics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

Who are the Major Competitors in the Addictions Therapeutics Market Outlook?

Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

What Is Fueling Growth in the Addictions Therapeutics Market?

The surge in alcohol consumption is projected to fuel the expansion of the addiction therapeutics market. The act of drinking alcoholic beverages containing ethyl alcohol is what’s referred to as alcohol consumption. Therapies for addiction are designed to manage alcohol addiction, helping individuals to reduce their alcohol intake by mitigating the depressive impact of alcohol and maintaining a balance between the stimulatory and inhibitory neurotransmitters glutamate and gamma-aminobutyric acid, which lessens the cravings for alcohol and soothes withdrawal symptoms such as insomnia, anxiety, and restlessness. For instance, a report released by Statistics Canada in February 2023 indicated that sales of alcoholic beverages in retail establishments and liquor authorities added up to $26.1 billion in the fiscal year that ended on March 31, 2022. This represented a 2.4% rise from the year before. Wine sales increased by 2.1%, touching $8.1 billion during the same timeframe. Breaking down the overall sales, beer represented 34.9% of the total alcohol sales value in 2021-2022, followed by wine with 31.3%, spirits with 25.8%, and ciders and coolers at 8.0%. As a result, the escalating consumption of alcohol is driving the growth of the addiction therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp

Which Addictions Therapeutics Market Segments Are Growing the Fastest?

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

5) By Application: Public, Private, Government

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix)

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

Which Industry Trends Are Shaping the Future of the Addictions Therapeutics Market?

Large corporations in the addiction therapeutics market are striving to broaden their customer reach, boost their sales, and increase their revenue by introducing novel products such as medications for cocaine use disorders (CUD). These drugs are formulated to assist individuals grappling with cocaine addiction or dependency. For example, in January 2023, Tempero Bio, a biopharmaceutical company based in the US, disclosed that the U.S. Food and Drug Administration (FDA) gave the green light for TMP-301. This investigative candidate of the company, TMP-301, is distinguished by its function as a negating allosteric modulator (NAM) of the metabotropic glutamate receptor 5 (mGluR5). TMP-301, which is specifically designed to play a pivotal role in combating cocaine use disorders (CUD), is renowned for its power, selectivity, oral availability, and its capability to effectively control the excessive glutamate signaling related to CUD.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Countries Are Leading the Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12129

This Report Delivers Insight On:

1. How big is the addictions therapeutics market, and how is it changing globally?

2. Who are the major companies in the addictions therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the addictions therapeutics market right now?

4. Which products or customer segments are growing the most in the addictions therapeutics market?

5. What factors are helping or slowing down the growth of the addictions therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model